Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity

The immune response to SARS-CoV-2 for patients with altered immunity such as hematologic malignancies and autoimmune disease may differ substantially from that in general population. These patients remain at high risk despite wide-spread adoption of vaccination. It is critical to examine the differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dongjoo, Biancon, Giulia, Bai, Zhiliang, VanOudenhove, Jennifer, Liu, Yuxin, Kothari, Shalin, Gowda, Lohith, Kwan, Jennifer M., Buitrago-Pocasangre, Nicholas Carlos, Lele, Nikhil, Asashima, Hiromitsu, Racke, Michael K., Wilson, JoDell E., Givens, Tara S., Tomayko, Mary M., Schulz, Wade L., Longbrake, Erin E., Hafler, David A., Halene, Stephanie, Fan, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460970/
https://www.ncbi.nlm.nih.gov/pubmed/36093346
http://dx.doi.org/10.1101/2022.08.31.506117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460970/
https://www.ncbi.nlm.nih.gov/pubmed/36093346
http://dx.doi.org/10.1101/2022.08.31.506117

Ejemplares similares